GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...
As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.
A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...
This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...
"It was the strangest feeling, because I never felt better about my physical appearance, but I also didn't want my husband to ...
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...
The Study is designed mainly to determine whether Lexaria’s proprietary DehydraTECH technology improves the safety and effectiveness of existing GLP-1 drugs. “Achieving the first patient, first dose ...
Merck is finally making a move in obesity by licensing an oral GLP-1 candidate, though it’s happening years after some of its big pharma peers … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback